InvestorsHub Logo
Followers 128
Posts 2150
Boards Moderated 1
Alias Born 12/27/2007

Re: None

Monday, 08/08/2016 10:24:10 AM

Monday, August 08, 2016 10:24:10 AM

Post# of 12450
IGXT-DD UPDATE // LIFETIME OPPORTUNITY HERE

Undiscovered Intelgenx (IGXT) is definitely one of the most attractive and undervalued stock in the Biotech Sector . The Company has already 2 Drugs approved and another 2 Big Drugs close to FDA approval .BIG Partnership News could come any day for up to 3 Drugs for which IGXT got a Therm Sheet from a Global Pharma Company and there are another partnering discussion ongoing for 2 Drugs (see pipeline chart below) .Their unique Thin-film version of the Blockbuster Drug Cialis (Erectile Dysfunction) alone is worth $2-3 per share , NDA filing for the Drug coming before Year end .

IGXT has a ridiculous Market Cap of US$46 Million which is a Big Joke for a Company with such a MEGA Product Pipeline , this Co has everything to be the next 10 Bagger minimum .GL

Intelgenx (IGXT) (IGX.V)

Market Cap: $46 Million
Cash: $8.1 Million
Price: $0.72

Burn-Rate: ~$400k per Quarter
Shares Out : 63.6 Million


Upcoming Milestones :


Product :Rizaport (Migraine)
•European Mktg Approval–November 2015
•Planned USA submission to FDA Q4/2016
•Expected USA launch Q2/2017



Product :Tadalafil (Erectile Dysfunction)
•505(b)(2) USA NDA submission in Q4/2016
•Expected USA launch Q4/2017



Product :Indicated for Opioid Dependence
•Awaiting FDA approval
•According to IMS data, the oral film market for opioid dependence was worth more than $1.4B US in 2014.



IntelGenx to Initiate Phase 1 Trial of Montelukast
IntelGenx Corp., today announced the recent initiation of a phase 1 clinical trial of montelukast, a unique drug repurposing opportunity for the treatment of degenerative diseases of the brain, such as: mild cognitive impairment and Alzheimers disease, the most prominent form of dementia. IntelGenx expects results from the phase 1 trial to be available in September 2016.


Presentation July 2016
http://s2.q4cdn.com/790425727/files/doc_presentations/2016/INTELGENX_July-6_2016-%281%29.pdf


The wonder pill that could STOP your brain ageing: Common asthma drug may be a cure for Alzheimer's, claims study..
http://www.dailymail.co.uk/sciencetech/article-3290482/The-wonder-pill-STOP-ageing-Common-asthma-drug-cure-Alzheimer-s-claims-study.html

Product Pipeline
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IGXT News